KPIs & Operating Metrics(New)
Growth Metrics

AbbVie (ABBV) Shareholder's Equity Growth (1y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -555.27%
Dec 31, 2025 -197.21%
Sep 30, 2025 -143.52%
Jun 30, 2025 -102.02%
Mar 31, 2025 -81.83%
Dec 31, 2024 -67.64%
Sep 30, 2024 -49.95%
Jun 30, 2024 -47.12%
Mar 31, 2024 -39.51%
Dec 31, 2023 -39.86%
Sep 30, 2023 -24.32%
Jun 30, 2023 -12.19%
Mar 31, 2023 -18.46%
Dec 31, 2022 11.99%
Sep 30, 2022 18.05%
Jun 30, 2022 16.63%
Mar 31, 2022 18.79%
Dec 31, 2021 17.86%
Sep 30, 2021 -11.20%
Jun 30, 2021 -14.51%
Mar 31, 2021 285.21%
Dec 31, 2020 260.27%
Sep 30, 2020 285.86%
Jun 30, 2020 271.98%
Mar 31, 2020 5.25%
Dec 31, 2019 3.24%
Sep 30, 2019 -181.62%
Jun 30, 2019 -153.81%
Mar 31, 2019 -320.26%
Dec 31, 2018 -265.71%
Sep 30, 2018 -95.78%
Jun 30, 2018 -6,126.79%
Mar 31, 2018 380.87%
Dec 31, 2017 9.94%
Sep 30, 2017 -34.90%
Jun 30, 2017 3.70%
Mar 31, 2017 -16.91%
Dec 31, 2016 17.52%
Sep 30, 2016 -1,386.05%
Jun 30, 2016 102.27%
Mar 31, 2016 6.08%
Dec 31, 2015 126.46%
Sep 30, 2015 109.42%
Jun 30, 2015 -145.50%
Mar 31, 2015 -124.53%
Dec 31, 2014 -61.22%
Sep 30, 2014 -125.52%
Jun 30, 2014 46.66%
Mar 31, 2014 58.84%
Dec 31, 2013 2,381.77%